MAPK3 and glioma: Our results demonstrate that [Ca2+]i-dependent glycogenolysis is required for TMZ resistance, stimulated by both the transactivation of Na,K-ATPase/ERK1/2 and the upregulation of MGMT expression in glioma cells.